Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
The purpose of this study is to compare the effects, good and/or bad, of cetuximab on lung cancer. Participants in this study have been diagnosed with advanced non-small cell lung cancer (NSCLC). Participants will be randomized to receive either chemotherapy without cetuximab or chemotherapy with cetuximab. Randomization means that participants are put into a group by chance.
Back to Clinical Trials list